21 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34541032 | Scaffold attachment factor B1 regulates androgen degradation pathways in prostate cancer. | 2021 | 1 |
2 | 32047296 | Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression. | 2020 Mar | 1 |
3 | 30262668 | Loss of dihydrotestosterone-inactivation activity promotes prostate cancer castration resistance detectable by functional imaging. | 2018 Nov 16 | 1 |
4 | 28404691 | Exemestane and Its Active Metabolite 17-Hydroexemestane Induce UDP-Glucuronosyltransferase (UGT) 2B17 Expression in Breast Cancer Cells. | 2017 Jun | 1 |
5 | 26797685 | Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression. | 2016 Apr | 2 |
6 | 26163549 | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 2015 Sep | 1 |
7 | 21541968 | Correlation between circulatory, local prostatic, and intra-prostatic androgen levels. | 2011 Jun 15 | 1 |
8 | 20628005 | A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide. | 2010 Oct | 1 |
9 | 19218247 | Human cytosolic hydroxysteroid dehydrogenases of the aldo-ketoreductase superfamily catalyze reduction of conjugated steroids: implications for phase I and phase II steroid hormone metabolism. | 2009 Apr 10 | 1 |
10 | 18467088 | Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling. | 2008 Apr | 1 |
11 | 18471784 | Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate. | 2008 Apr | 1 |
12 | 17698910 | The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. | 2007 Dec | 2 |
13 | 17826523 | Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk. | 2007 Aug | 4 |
14 | 16595710 | Human UDP-glucuronosyltransferase, UGT1A8, glucuronidates dihydrotestosterone to a monoglucuronide and further to a structurally novel diglucuronide. | 2006 Jul | 1 |
15 | 11159850 | Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. | 2001 Feb | 2 |
16 | 10339403 | Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution. | 1999 May 28 | 2 |
17 | 9569009 | Effect of fibroblastic growth factors (FGF) on steroid UDP-glucuronosyltransferase expression and activity in the LNCaP cell line. | 1998 Jan | 2 |
18 | 9699884 | Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. | 1998 Apr | 3 |
19 | 9202245 | Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. | 1997 Jul | 2 |
20 | 9364925 | Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme. | 1997 Oct | 5 |
21 | 8798464 | Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. | 1996 Sep 13 | 1 |